边缘地带
生物
淋巴毒素
细胞生物学
脾脏
平衡
免疫系统
免疫学
B细胞
抗体
病毒学
自然杀伤细胞
细胞
获得性免疫系统
树突状细胞
巨细胞病毒
病毒
作者
Xinyuan Liu,Filiz Demircik,M. V. Antipova,Georgios Tavoulareas,Matthias Klein,David Alejandro Bejarano,Abdelrahman Elwy,Anna Ebering,Michaela Blanfeld,Katlynn Carter,Lisa Johann,David C. Uhlfelder,Elisa Blickberndt,Yao Chen,H. Probst,Nadine Hövelmeyer,Tobias Bopp,Ramon Arens,Lukas Bunse,Joke M. M. den Haan
标识
DOI:10.1038/s41423-026-01392-0
摘要
Natural killer and CD8+ T cells are critical in the elimination of blood-borne viruses such as cytomegalovirus (CMV); however, the role of B cells in this process is less clear. Here, using a murine CMV (MCMV) infection model, we demonstrated that B-cell-deficient mice mounted a weaker primary virus-specific CD8+ T-cell response than their wild-type counterparts did, which was associated with increased viral transcription. Notably, we found that the contribution of B cells to the CD8+ T-cell-mediated antiviral response was not associated with their ability to generate antibodies but with their ability to sustain Langerin+ type 1 conventional dendritic cells (cDC1s), a dendritic cell (DC) subset known for being involved in viral and bacterial clearance in the marginal zone of the spleen. Furthermore, we found that the presence of Langerin+ cDC1s is dependent on B cells expressing lymphotoxin (LTβ) to maintain CD169+ marginal metallophilic macrophages (MMMs). We further discovered, via ligand‒receptor interaction analyses, that the communication between MMMs and Langerin+ cDC1s was mediated via the VCAM1-ITGA4/ITGB1 interaction. Thus, our data reveal that B cells regulate the development of MMMs in the spleen via LTβ expression and consequently sustain Langerin+ cDC1 homeostasis for effective initiation of an antiviral CD8+ T-cell response. Overall, our study offers a new perspective on how B cells maintain the homeostasis of antigen-presenting cells in the splenic marginal zone and thus indirectly affect the virus-specific CD8+ T-cell response, which could be extended to other infectious and autoimmune diseases as well as tumors.
科研通智能强力驱动
Strongly Powered by AbleSci AI